These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
330 related items for PubMed ID: 11511535
1. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Bouchard C, Dittrich O, Kiermaier A, Dohmann K, Menkel A, Eilers M, Lüscher B. Genes Dev; 2001 Aug 15; 15(16):2042-7. PubMed ID: 11511535 [Abstract] [Full Text] [Related]
2. Mnt transcriptional repressor is functionally regulated during cell cycle progression. Popov N, Wahlström T, Hurlin PJ, Henriksson M. Oncogene; 2005 Dec 15; 24(56):8326-37. PubMed ID: 16103876 [Abstract] [Full Text] [Related]
3. Down-regulation of TRRAP-dependent hTERT and TRRAP-independent CAD activation by Myc/Max contributes to the differentiation of HL60 cells after exposure to DMSO. Jiang G, Bi K, Tang T, Wang J, Zhang Y, Zhang W, Ren H, Bai H, Wang Y. Int Immunopharmacol; 2006 Jul 15; 6(7):1204-13. PubMed ID: 16714225 [Abstract] [Full Text] [Related]
4. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. Bouchard C, Thieke K, Maier A, Saffrich R, Hanley-Hyde J, Ansorge W, Reed S, Sicinski P, Bartek J, Eilers M. EMBO J; 1999 Oct 01; 18(19):5321-33. PubMed ID: 10508165 [Abstract] [Full Text] [Related]
5. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc. Yang W, Shen J, Wu M, Arsura M, FitzGerald M, Suldan Z, Kim DW, Hofmann CS, Pianetti S, Romieu-Mourez R, Freedman LP, Sonenshein GE. Oncogene; 2001 Mar 29; 20(14):1688-702. PubMed ID: 11313917 [Abstract] [Full Text] [Related]
6. Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells. Delgado MD, Lerga A, Cañelles M, Gómez-Casares MT, León J. Oncogene; 1995 Apr 20; 10(8):1659-65. PubMed ID: 7731722 [Abstract] [Full Text] [Related]
7. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation. Lüscher B, Larsson LG. Oncogene; 1999 May 13; 18(19):2955-66. PubMed ID: 10378692 [Abstract] [Full Text] [Related]
8. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins. Cerni C, Bousset K, Seelos C, Burkhardt H, Henriksson M, Lüscher B. Oncogene; 1995 Aug 03; 11(3):587-96. PubMed ID: 7630643 [Abstract] [Full Text] [Related]
9. Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells. Larsson LG, Bahram F, Burkhardt H, Lüscher B. Oncogene; 1997 Aug 07; 15(6):737-48. PubMed ID: 9264414 [Abstract] [Full Text] [Related]
10. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: Differential regulation of mad family and stress-mediated induction of c-myc. Mauleon I, Lombard MN, Muñoz-Alonso MJ, Cañelles M, Leon J. Mol Carcinog; 2004 Feb 07; 39(2):85-90. PubMed ID: 14750213 [Abstract] [Full Text] [Related]
11. Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1. Pulverer B, Sommer A, McArthur GA, Eisenman RN, Lüscher B. J Cell Physiol; 2000 Jun 07; 183(3):399-410. PubMed ID: 10797315 [Abstract] [Full Text] [Related]
12. Repression by the Mad(Mxi1)-Sin3 complex. Schreiber-Agus N, DePinho RA. Bioessays; 1998 Oct 07; 20(10):808-18. PubMed ID: 9819568 [Abstract] [Full Text] [Related]
13. Regulation of human ornithine decarboxylase expression following prolonged quiescence: role for the c-Myc/Max protein complex. Peña A, Wu S, Hickok NJ, Soprano DR, Soprano KJ. J Cell Physiol; 1995 Feb 07; 162(2):234-45. PubMed ID: 7822433 [Abstract] [Full Text] [Related]
14. Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Xu D, Popov N, Hou M, Wang Q, Björkholm M, Gruber A, Menkel AR, Henriksson M. Proc Natl Acad Sci U S A; 2001 Mar 27; 98(7):3826-31. PubMed ID: 11274400 [Abstract] [Full Text] [Related]
15. DNA binding of Myc/Max/Mad network complexes to oligonucleotides containing two E box elements: c-Myc/Max heterodimers do not bind DNA cooperatively. Vervoorts J, Lüscher B. Biol Chem; 1999 Sep 27; 380(9):1121-6. PubMed ID: 10543451 [Abstract] [Full Text] [Related]
16. The inhibition of cyclin B1 gene transcription in quiescent NIH3T3 cells is mediated by an E-box. Farina A, Gaetano C, Crescenzi M, Puccini F, Manni I, Sacchi A, Piaggio G. Oncogene; 1996 Sep 19; 13(6):1287-96. PubMed ID: 8808703 [Abstract] [Full Text] [Related]
17. Mnt takes control as key regulator of the myc/max/mxd network. Wahlström T, Henriksson M. Adv Cancer Res; 2007 Sep 19; 97():61-80. PubMed ID: 17419941 [Abstract] [Full Text] [Related]
18. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts. Marcotte R, Chen JM, Huard S, Wang E. J Cell Biochem; 2005 Dec 01; 96(5):1071-85. PubMed ID: 16167342 [Abstract] [Full Text] [Related]
19. Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Frank SR, Schroeder M, Fernandez P, Taubert S, Amati B. Genes Dev; 2001 Aug 15; 15(16):2069-82. PubMed ID: 11511539 [Abstract] [Full Text] [Related]
20. Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc. Pawar SA, Szentirmay MN, Hermeking H, Sawadogo M. Oncogene; 2004 Aug 12; 23(36):6125-35. PubMed ID: 15208653 [Abstract] [Full Text] [Related] Page: [Next] [New Search]